Table 6.

Multivariate logistic regression analysis of potential risk factors for T upstaging as a result of mpMRI

	OR	95% confidence interval	p-value
Low-risk PSA (<10 ng/ml)	0.37	(0.11, 1.15)	0.096
Intermediate-risk PSA (10–20 ng/ml)	0.29	(0.08, 0.93)	0.043
Low-risk Gleason score (<7)	0.99	(0.27, 3.65)	0.99
Intermediate-risk Gleason score (7)	1.88	(0.51, 7.11)	0.34
Age	1.02	(0.95, 1.10)	0.54
ADT pre-mpMRI	1.34	(0.55, 3.25)	0.52

Multivariate logistic regression analysis was used to demonstrate the relative probability of tumor upstaging after mpMRI of the prostate in patients initially staged as cT1-cT2 (n = 97) depending on specific patient parameters. Patients in the intermediate-risk PSA group had a significantly lower probability of upstaging due to mpMRI than patients in the high-risk PSA group (p = 0.043). OR = Odds ratio. ADT = Androgen deprivation therapy.